WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Kenya’s 2026 local medicine target slips away as import bill nears Sh100bn

Despite constraints, Kenya remains the most advanced pharmaceutical manufacturer in East Africa and the third-largest exporter of pharmaceuticals on the continent.

Raccontata dabusinessdailyafrica.comstandardmedia.co.ke

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
businessdailyafrica.comStai leggendo8 g fa

Kenya’s 2026 local medicine target slips away as import bill nears Sh100bn

Despite constraints, Kenya remains the most advanced pharmaceutical manufacturer in East Africa and the third-largest exporter of pharmaceuticals on the continent.

originale
standardmedia.co.ke5 g fa

Kenya in a drive to attain WHO medicine production level in the next five months

Kenya is ramping up efforts to attain the World Health Organization's (WHO) Maturity Level 3 (ML3) status in pharmaceutical regulation by December this year.

Leggi questa versione → originale

Timeline cronologica

  1. mercoledì 24 giugno 2026·businessdailyafrica.com

    Kenya’s 2026 local medicine target slips away as import bill nears Sh100bn

    Despite constraints, Kenya remains the most advanced pharmaceutical manufacturer in East Africa and the third-largest exporter of pharmaceuticals on the continent.

  2. sabato 27 giugno 2026·standardmedia.co.ke

    Kenya in a drive to attain WHO medicine production level in the next five months

    Kenya is ramping up efforts to attain the World Health Organization's (WHO) Maturity Level 3 (ML3) status in pharmaceutical regulation by December this year.